Thrombus Embolisation: Prevention is Better than Cure

Thrombus embolisation complicating primary percutaneous coronary intervention in ST-elevation myocardial infarction is associated with an increase in adverse outcomes. However, there are currently no proven recommendations for intervention in the setting of large thrombus burden. In this review, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Choudry, Fizzah A, Weerackody, Roshan P, Jones, Daniel A, Mathur, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2019
Materias:
Coronary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545997/
https://www.ncbi.nlm.nih.gov/pubmed/31178936
http://dx.doi.org/10.15420/icr.2019.11
_version_ 1783423481770147840
author Choudry, Fizzah A
Weerackody, Roshan P
Jones, Daniel A
Mathur, Anthony
author_facet Choudry, Fizzah A
Weerackody, Roshan P
Jones, Daniel A
Mathur, Anthony
author_sort Choudry, Fizzah A
collection PubMed
description Thrombus embolisation complicating primary percutaneous coronary intervention in ST-elevation myocardial infarction is associated with an increase in adverse outcomes. However, there are currently no proven recommendations for intervention in the setting of large thrombus burden. In this review, we discuss the clinical implications of thrombus embolisation and angiographic predictors of embolisation, and provide an update of current evidence for some preventative strategies, both pharmacological and mechanical, in this setting.
format Online
Article
Text
id pubmed-6545997
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Radcliffe Cardiology
record_format MEDLINE/PubMed
spelling pubmed-65459972019-06-07 Thrombus Embolisation: Prevention is Better than Cure Choudry, Fizzah A Weerackody, Roshan P Jones, Daniel A Mathur, Anthony Interv Cardiol Coronary Thrombus embolisation complicating primary percutaneous coronary intervention in ST-elevation myocardial infarction is associated with an increase in adverse outcomes. However, there are currently no proven recommendations for intervention in the setting of large thrombus burden. In this review, we discuss the clinical implications of thrombus embolisation and angiographic predictors of embolisation, and provide an update of current evidence for some preventative strategies, both pharmacological and mechanical, in this setting. Radcliffe Cardiology 2019-05-21 /pmc/articles/PMC6545997/ /pubmed/31178936 http://dx.doi.org/10.15420/icr.2019.11 Text en Copyright © 2019, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/legalcode This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly.
spellingShingle Coronary
Choudry, Fizzah A
Weerackody, Roshan P
Jones, Daniel A
Mathur, Anthony
Thrombus Embolisation: Prevention is Better than Cure
title Thrombus Embolisation: Prevention is Better than Cure
title_full Thrombus Embolisation: Prevention is Better than Cure
title_fullStr Thrombus Embolisation: Prevention is Better than Cure
title_full_unstemmed Thrombus Embolisation: Prevention is Better than Cure
title_short Thrombus Embolisation: Prevention is Better than Cure
title_sort thrombus embolisation: prevention is better than cure
topic Coronary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6545997/
https://www.ncbi.nlm.nih.gov/pubmed/31178936
http://dx.doi.org/10.15420/icr.2019.11
work_keys_str_mv AT choudryfizzaha thrombusembolisationpreventionisbetterthancure
AT weerackodyroshanp thrombusembolisationpreventionisbetterthancure
AT jonesdaniela thrombusembolisationpreventionisbetterthancure
AT mathuranthony thrombusembolisationpreventionisbetterthancure

Ejemplares similares